	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549
	SCHEDULE 13G (Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

Under the Securities Exchange Act of 1934
(Amendment No. )*

Obagi Medical Products, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

67423R 10 8

(CUSIP Number)

February 14, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o	Rule 13d-1(b)
o	Rule 13d-1(c)
x	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 67423R108

	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Lucy McNamara

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization United States of America

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 1,875,001

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 1,875,001

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,875,001

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 8.6%

	12.	Type of Reporting Person (See Instructions) IN

CUSIP No. 67423R108

	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) McNamara Family Irrevocable Trust Under Agreement Dated December 17, 2004

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization State of Connecticut, United States of America

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 1,875,001

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 1,875,001

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,875,001

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 8.6%

	12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 67423R108

	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) McNamara Family Trust Under Agreement Dated December 27, 2004

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x

	3.	SEC Use Only

	4.	Citizenship or Place of Organization State of California, United States of America

Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0

			6.		Shared Voting Power 1,875,001

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 1,875,001

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,875,001

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 8.6%

	12.	Type of Reporting Person (See Instructions) OO

CUSIP No. 67423R108

Item 1.
	(a)	Name of Issuer The name of the issuer is Obagi Medical Products, Inc. (the “Issuer”).
	(b)	Address of Issuer’s Principal Executive Offices The address of the Issuer’s principal executive office is 310 Golden Shore, Long Beach, California 90802.

Item 2.
	(a)	Name of Person Filing The Reporting Persons are McNamara Family Irrevocable Trust Under Agreement Dated December 17, 2004 (the “Irrevocable Trust”) and McNamara Family Trust Under Agreement Dated December 27, 2004 (the “Family Trust” and together with the Irrevocable Trust, the “Trusts”) and Lucy McNamara as trustee of the Trusts. The Trusts and Lucy McNamara are collectively referred to as the “Reporting Persons.”
	(b)	Address of Principal Business Office or, if none, Residence The business address of the Reporting Persons is c/o David I. Sunkin, Esq., Sheppard Mullin Richter & Hampton LLP, 333 South Hope Street, 48th Floor, Los Angeles, California 90071.
	(c)	Citizenship Lucy McNamara is a citizen of the United States of America. The Irrevocable Trust is formed in the State of Connecticut, United States of America and the Family Trust is formed in the State of California, United States of America .
	(d)	Title of Class of Securities The title of the class of securities to which this statement relates is the common stock, par value $0.001 per share, of the Issuer (the “Common Stock”).
	(e)	CUSIP Number The CUSIP number is 67423R 10 8.

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
	(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
	(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	o	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	o	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	o	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	o	Group, in accordance with §240.13d-1(b)(1)(ii)(J).
	Not applicable

CUSIP No. 67423R108

Item 4.	Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
	(a)	Amount beneficially owned: 1,875,001 shares of common stock.
	(b)	Percent of class: 8.6% based on number of outstanding shares of Common Stock of 17,799,183 as of September 30, 2006, as reported in the Issuer’s Registration Statement on Form S-1, File No. 333-137272, as amended, as filed with the Securities and Exchange Commission on December 12, 2006 (the “Registration Statement”).
	(c)	Number of shares as to which the person has:
		(i)	Sole power to vote or to direct the vote 0
		(ii)	Shared power to vote or to direct the vote 1,875,001
		(iii)	Sole power to dispose or to direct the disposition of 0
		(iv)	Shared power to dispose or to direct the disposition of 1,875,001
This Schedule 13G filing includes 416,667 shares of the Issuer held by the Irrevocable Trust and 1,458,334 shares of Common Stock held by the Family Trust. Lucy McNamara is trustee of the Trusts and has voting and dispositive power over the securities held by the Trusts. Ms. McNamara disclaims beneficial ownership of the securities held by the Trusts except for her pecuniary interest therein. The Trusts are subject to a market standoff agreement pursuant to Section 2.9 of the Investor’s Rights Agreement dated April 1, 2002, between the Issuer and Austin T. McNamara (the “Agreement”) which has been filed as Exhibit 4.2 to the Registration Statement. Pursuant to the Agreement, for a market stand-off time period not to exceed 180 days from December 13, 2006 (the effective date of the Registration Statement), Mr. McNamara shall not, to the extent requested by the Issuer and an underwriter of common stock of the Issuer, directly or indirectly sell, offer to sell, contract to sell (including, without limitation, any short sale), grant any option to purchase or otherwise transfer or dispose of any securities of the Issuer held by him. The Trusts intend to review continuously their equity position in the Issuer. Depending upon their future evaluation of the business and prospects of the Issuer and upon other developments, including, but not limited to, general economic conditions and investment and stock market conditions, the Trusts may determine to decrease their equity interest in the Issuer by disposing of all or a portion of their shares. The above description of the Agreement is only a summary and is qualified in its entirety be reference to the Agreement, filed as Exhibit 4.2 to the Registration Statement.

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
Not Applicable.

Item 6.	Ownership of More than Five Percent on Behalf of Another Person
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Not Applicable.

CUSIP No. 67423R108

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
If a parent holding company or control person has filed this Schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this Schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Not Applicable.

Item 8.	Identification and Classification of Members of the Group
If a group has filed this Schedule pursuant to Rule 13d-1(b)(1)(ii)(J), so indicate under item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this Schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Not Applicable.

Item 9.	Notice of Dissolution of Group
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Not Applicable.

Item 10.	Certification
Not Applicable.

CUSIP No. 67423R108

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2007	By:	/s/ LUCY MCNAMARA
		LUCY MCNAMARA


Date: February 14, 2007	MCNAMARA IRREVOCABLE
	FAMILY TRUST UNDER
	AGREEMENT DATED DECEMBER
	17, 2004

	By:	/s/ LUCY MCNAMARA
		Lucy McNamara
		Trustee

Date: February 14, 2007	MCNAMARA FAMILY TRUST
	UNDER AGREEMENT DATED
	DECEMBER 27, 2004

	By:	/s/ LUCY MCNAMARA
		Lucy McNamara
		Trustee

CUSIP No. 67423R108

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Report on Schedule 13G (including amendments thereto) with respect to the common stock of Obagi Medical Products, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such Report. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

In evidence whereof, the undersigned have caused this agreement to be executed on their behalf this 14th day of February, 2007.

	By:	/s/ LUCY MCNAMARA
		LUCY MCNAMARA


	MCNAMARA IRREVOCABLE
	FAMILY TRUST UNDER AGREEMENT
	DATED DECEMBER 17, 2004


	By:	/s/ LUCY MCNAMARA
		Lucy McNamara
		Trustee

	MCNAMARA FAMILY TRUST UNDER
	AGREEMENT DATED DECEMBER 27, 2004
	By:	/s/ LUCY MCNAMARA
		Lucy McNamara
		Trustee